RBOT · Vicarious Surgical Inc.
$0.90
At close · Mar 4
Return incl. dividend (before tax)
Going-concern doubt
— flagged Apr 30, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management does not believe that the Company’s cash, cash equivalents and short-term investments balance at March 31, 2026 of $3,682 will be sufficient to support the Company’s operations for the next twelve months from the date of issuance of these financial statements, and accordingly, this raises substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Apr 30, 2026
Market Cap
$284,969
Shares
7.12M
Volume · Mar 4
334.8K
Avg daily vol (3M)
144.18K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.90
Open$1.20
Day$0.52–1.50
52W close$0.90–13.19
Avg vol 30d85K
Short int136K · 1.9% float · 1.2d
Short vol41%
Last earningsMar 9, 2026
DataSep 2020–Mar 2026
Filing10-Q · Apr 30
Up next
filed Apr 30, 2026
call held Nov 12, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$42.12M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+20.2%
Year over year · more shares
Price change (1Y)
-91.0%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−59%
below
RSI (14)
25
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−57%
trailing
6-month return
−85%
trailing
YTD return
−59%
this year
Relative strength
−91%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.92% of float · ▲ +7.6% MoM · 1.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
EPS growth
−1325%
Y/Y
Free cash flow
$-45.2M
Balance sheet
$50.8M
net cash
Quant / Vol
risk profile
Volatility
121%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
34.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Mar 9, 2026
Full year 2026 cash burn
· full year 2026
$19M
Prior guidance
period ended
· from the Earnings Call filed Nov 12, 2025
Cash burn
· full year 2025
$50M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−59%
Bearish
RSI (14)
25
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.92% of float · ▲ +7.6% MoM · 1.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1
Now $1 · 0%
Range high $13
vs 200-day avg -83%
vs 50-day avg -59%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RBOT
this stock
Vicarious Surgical Inc.
|
$284,969 | -58.6% | — | — | 1.9% |
|
ABT
Abbott Laboratories
|
$179.20B | -18.2% | +5.7% | 33.3 | 0.8% |
|
MDT
Medtronic plc
|
$118.67B | -1.5% | +8.4% | 22.9 | 3.1% |
|
SYK
Stryker Corp
|
$114.28B | -13.4% | +11.2% | 30.9 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.02B | -52.2% | +12.5% | 18.4 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RBOT | -55.3% | -57.0% | -85.5% | -55.9% | -58.6% |
| SPY | -1.2% | -0.6% | +5.1% | -0.1% | +0.5% |
| vs SPY | -54.1% | -56.4% | -90.5% | -55.8% | -59.0% |